Bristol-Myers Squibb buy Cantor Fitzgerald
Start price
15.09.23
/
50%
€55.30
Target price
15.09.24
€70.25
Performance (%)
-23.06%
Price
10:29
€40.91
Summary
This prediction is currently active. The prediction for Bristol-Myers Squibb disappoints with a performance of -23.06%. A total of €1.64 was paid as dividends for this prediction. This prediction currently runs until 15.09.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -2.493% | -2.493% |
| iShares Core DAX® | -0.922% | -1.078% |
| iShares Nasdaq 100 | 0.371% | -0.556% |
| iShares Nikkei 225® | 2.224% | -2.825% |
| iShares S&P 500 | -0.026% | -0.788% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol-Myers Squibb (NYSE: BMY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $75.00 price target on the stock.
Ratings data for BMY provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€53.40
09.10.23
09.10.23
€71.08
09.10.24
09.10.24
-21.21%
10:29
10:29
